European Companies Search Engine
Wordmark: “BO-112 Spotlight“ Euipotm 23 Dec 2020 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | BO-112 Spotlight |
| Filing number | 018282882 |
| Trade mark status | REGISTERED |
| Nice Classification |
42: Providing scientific and research information relating to pharmaceuticals; Providing scientific and research information relating to anti-cancer drugs and anti-cancer drug combinations; Providing scientific and research information relating to resistance or insensitivity of cancer to pharmaceuticals. 44: Providing medical information and services relating to pharmaceuticals; Internet-based medical information services and other advisory services in the field of health; Providing medical information and services relating to treatment of cancers and of drug-resistant cancers; Providing medical information and services relating to use of drug and therapy combinations for treating cancer; Providing information to patients in the field of administering anti-cancer drugs and anti-cancer drug combinations; Providing treatments for participants in clinical trials for oncology therapies. |
| Filing date | 03/08/2020 |
| Registration date | 18/12/2020 |
| Expiry date | 03/08/2030 |
| Owners |
HIGHLIGHT THERAPEUTICS S.L.
E-46980 Paterna, Valencia Spain |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Highlight Therapeutics SL, Paterna, Spain.
